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Chemoselective Cross-Coupling
Pyrimidin-6-yl Trifluoroborate Salts as Versatile Templates for
Heterocycle Synthesis
David L. Cousins, Prisca Fricero, Kenji P. M. Kopf, Elliot J. McColl, Werngard Czechtizky,
Yee Hwee Lim, and Joseph P. A. Harrity*
Abstract: We report a novel and general method to access
a highly under-studied privileged scaffold—pyrimidines bear-
ing a trifluoroborate at C4, and highlight the broad utility of
these intermediates in a rich array of downstream functional-
ization reactions. This chemistry is underpinned by the unique
features of the trifluoroborate group; its robustness provides an
opportunity to carry out chemoselective reactions at other
positions on the pyrimidine while providing a pathway for
elaboration at the CB bond when suitably activated.
Pyrimidines are amongst the most widely represented class
of heterocycles in biological systems. They are present in
nucleic acids and countless other biologically relevant com-
pounds, including numerous pharmaceutical and agrochem-
ical products (Figure 1).[1] Indeed, in 2020, 8 out of 35 small-
molecule drugs that gained FDA approval contained a pyr-
imidine heterocycle, demonstrating the continued demand for
ways to access this privileged substructure. In addition to their
ubiquity in the biological sciences, pyrimidine derivatives are
also common building blocks in many functional materials
such as supramolecular assemblies, non-linear optics and
organic electronics.[2]
The ring C–H metalation of pyrimidines offers a direct
means to further functionalize these systems,[3] and this has
been successfully implemented at C2,[4] C4,[5] and C5.[6]
However, ring metalation requires strong bases and often
leads to low yields of products due to the propensity of these
intermediates to undergo dimerization. In recent years, there
have been numerous reports of radical/homolytic functional-
ization of pyrimidines as a mild and functional group tolerant
alternative to deprotonative metalation.[7] Several notable
examples of this strategy have allowed the predictable,
selective and mild functionalization of pyrimidines under
photoredox catalysis and Minisci conditions.[8]
While this approach is powerful for pyrimidine alkylation
and (electron-rich) arylation at C4 due to the innate electro-
philicity of this ring position, metalation would prove
complementary to this strategy and so more robust C4
metalated pyrimidine derivatives would make a welcome
addition to the arsenal of methods available for pyrimidine
functionalization. In this regard, boronic acid derivatives offer
an intriguing alternative to main group organometallics as
they are generally stable, easy to handle and enjoy a rich array
of potential functionalization methods. We anticipated that
pyrimidine boronic acid derivatives would offer an estab-
lished route to a range of derivatization strategies. To our
surprise however, they are remarkably under-represented,
with the 4-borylated congener being the subject of only very
limited studies to-date. For catalytic transformations, this
fragment is typically supplanted by a (pseudo)halide in
Suzuki–Miyaura cross-couplings or an organotin reagent in
Stille cross couplings.[9] Among the possible reasons for this
may include the tendency for boronic acids and esters
adjacent to ring heteroatoms to undergo undesired side-
reactions, such as protodeboronation and oxidation.[10] Nota-
bly, attempts at catalytic borylation at the pyrimidine C6 have
Figure 1. Prominent pyrimidine containing heterocycles.
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been unsuccessful.[11] This adds to the incentive to develop
alternative approaches to access this important class of
intermediate.
Organotrifluoroborate salts offer a powerful means for
the isolation and utility of otherwise unstable/sensitive
boronic acids and esters.[12] As shown in Figure 2, we
recognized the opportunity to exploit ynone trifluoroborates
1[13] to access novel pyrimidines that would provide a platform
for a rich array of downstream manipulations. This scaffold
would demonstrate the unique chemoselectivity of the
trifluoroborate group that is available for derivatization
when activated under appropriate conditions, but is otherwise
unaffected during a range of other transformations.
We began our studies by investigating the condensation
reaction of amidines and ynone trifluoroborate salts and our
results are summarized in Figure 3. A brief optimization study
revealed that refluxing toluene promoted the smooth con-
densation of benzaminidine free base with a range of ynone
trifluoroborate salts to give the corresponding pyrimidine
borates in good yield. Encouragingly, with regard to the
ynone substituent, electron-rich, electron-poor, and halogen-
ated aromatics were tolerated. In addition, pyrazole-substi-
tuted ynone 1 i underwent smooth condensation with benza-
midine to afford 2 i which was isolated in excellent yield. The
procedure could also be applied to alkyl-substituted ynone
trifluoroborates, allowing the isolation of pyrimidines 2 f–h in
good yield. With regard to the amidine component, numerous
benzamidines were tolerated in this process to give pyrimi-
dines 2j–lwith various substituted aromatics in the 2-position.
Heteroaromatic fragments, along with a cyclopropyl substitu-
ent could also be incorporated, providing the corresponding
products in good yield.
A significant proportion of pyrimidine-containing drugs
contain a 2-amino substituent (cf. Figure 1), therefore, a prior-
ity for further scope investigation was to determine if this
important pharmacophore could be incorporated in the
structure of the product salts, via reaction of the appropriate
guanidine with our ynone salts. Starting with N-carbamimi-
doyl pivalamide as a non-hygroscopic and crystalline equiv-
alent of guanidine freebase, we were surprised to isolate free
aminopyrimidine 4awith no trace of the corresponding amide
(Figure 4).[14] This process appeared to be quite general and
delivered a small family of 2-aminopyrimidine borate salts in
good to excellent yields. We next turned our attention to the
condensation of N-substituted guanidines and again were
pleased to find that we could generate a range of N-
substituted analogs. In this case the products were isolated
with high regioselectivities after recrystallization, and the
regiochemistry was assigned on the basis of 1H NMR
spectroscopy, and by X-ray crystallography in the case of 6.[15]
Finally, and with a range of pyrimidine trifluoroborate
salts in hand, we decided to investigate the potential of these
compounds for further organic synthesis, with an emphasis on
highlighting chemoselective manipulations of the function-
ality present in these molecules. As shown in Figure 5,
treatment of 4a with MeI and allyl bromide resulted in the
Figure 2. Design strategy for the synthesis and functionalization of
pyrimidin-6-yl boronates.
Figure 3. Scope of pyrimidin-6-yl trifluoroborate salts. [a] 3.8 equiv of benzamidine used. [b] Reaction mixture was heated for 48 hours.
[c] 6.0 equiv of cyclopropylamidine used.
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formation of 10a,b. These compounds are isomers of 7 and 9
that were generated by direct condensation (cf Figure 4)
which serves to highlight the diversity of substitution avail-
able in the generation of these heterocyclic products. These
compounds were isolated as single regioisomers and the
regioselectivity was assigned by X-ray crystallography and
HMBC spectroscopy (see Supporting Information).[16] Turn-
ing to the trifluoroborate, we were pleased to find that this
group proved to be amenable to promoting cross-coupling
with aryl iodides, furnishing biaryl products 11a,b in good
yield. Finally, subjecting 4a to bromination results in clean
electrophilic aromatic substitution at the pyrimidine C5
position, leaving the trifluoroborate group intact. Subsequent
oxidation of the CB bond provided the experimental anti-
cancer drug, bropirimine in high yield over two steps.
In conclusion, we report that C4-borylated pyrimidine
derivatives can be readily accessed by condensation reactions
of ynone trifluoroborates, providing the first general method
to access this class of heterocycles. This work serves to
highlight the robustness of the potassium trifluoroborate
handle; it is stable towards strongly nucleophilic amidines and
guanidines, as well as alkylating agents and even bromine.
However, it also provides a pathway for elaboration of the
pyrimidines via Suzuki–Miyaura cross-coupling and oxida-
tion. The trifluoroborate salts presented herein are crystal-
line, bench-stable materials that have been stored without
precaution for more than 1 year, without noticeable degra-
dation. It is hoped that these compounds will find application
as robust intermediates in the synthesis of useful pyrimidines.
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Stable and enabling: Pyrimidine tri-
fluoroborates are an under-developed
scaffold that have been rarely reported in
the literature. These compounds partic-
ipate in a rich array of downstream func-
tionalization reactions that are under-
pinned by the unique features of the tri-
fluoroborate group; its robustness pro-
vides an opportunity to carry out che-
moselective reactions at other positions
on the pyrimidine while providing a path-
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